| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.681 | 0.008 | 0.707 | 5 Hydroxytryptamine release stimulant | 0.707 0.007 DBMET00314 0.547 0.02 DBMET00679 | DBMET00314 | |
| 0.645 | 0.005 | 0.645 | Psychostimulant | 0.609 0.005 DBMET00314 0.622 0.005 DBMET00679 | ||
| 0.576 | 0.009 | 0.576 | Calcium channel L-type activator | 0.571 0.009 DBMET00314 0.452 0.05 DBMET00679 | ||
| 0.543 | 0.004 | 0.543 | Alpha 2b adrenoreceptor antagonist | 0.488 0.004 DBMET00314 | ||
| 0.549 | 0.026 | 0.713 | Aldehyde oxidase inhibitor | 0.713 0.007 DBMET00314 | DBMET00314 | |
| 0.52 | 0.026 | 0.52 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.388 0.112 DBMET00314 | ||
| 0.503 | 0.009 | 0.503 | Sigma receptor agonist | 0.479 0.012 DBMET00314 0.141 0.092 DBMET00679 | ||
| 0.508 | 0.024 | 0.508 | GABA C receptor rho-3 antagonist | 0.507 0.024 DBMET00314 | ||
| 0.504 | 0.022 | 0.667 | Spasmolytic | 0.561 0.017 DBMET00314 0.667 0.008 DBMET00679 | DBMET00679 | |
| 0.51 | 0.056 | 0.644 | Caspase 9 stimulant | 0.644 0.03 DBMET00314 0.601 0.036 DBMET00679 | DBMET00314 | |
| 0.46 | 0.007 | 0.46 | 5 Hydroxytryptamine 2 antagonist | 0.326 0.014 DBMET00314 | ||
| 0.452 | 0.005 | 0.452 | Nav1.2 sodium channel blocker | 0.354 0.01 DBMET00314 | ||
| 0.449 | 0.003 | 0.449 | 5 Hydroxytryptamine 5A antagonist | 0.306 0.004 DBMET00314 | ||
| 0.439 | 0.005 | 0.439 | 5 Hydroxytryptamine 2C antagonist | 0.293 0.009 DBMET00314 | ||
| 0.44 | 0.009 | 0.44 | 5 Hydroxytryptamine antagonist | 0.262 0.023 DBMET00314 | ||
| 0.432 | 0.004 | 0.432 | Nav1.3 sodium channel blocker | 0.31 0.008 DBMET00314 | ||
| 0.428 | 0.007 | 0.428 | 5 Hydroxytryptamine 2B antagonist | 0.322 0.013 DBMET00314 | ||
| 0.409 | 0.003 | 0.409 | 5 Hydroxytryptamine 5 antagonist | 0.281 0.004 DBMET00314 | ||
| 0.395 | 0.004 | 0.395 | Alpha 2c adrenoreceptor antagonist | 0.364 0.005 DBMET00314 0.088 0.077 DBMET00679 | ||
| 0.388 | 0.005 | 0.388 | Alpha 2a adrenoreceptor antagonist | 0.384 0.005 DBMET00314 | ||
| 0.39 | 0.01 | 0.39 | Alpha adrenoreceptor antagonist | 0.346 0.012 DBMET00314 | ||
| 0.385 | 0.005 | 0.385 | 5 Hydroxytryptamine uptake inhibitor | 0.219 0.01 DBMET00314 | ||
| 0.399 | 0.025 | 0.399 | Calcium channel activator | 0.377 0.034 DBMET00314 | ||
| 0.383 | 0.024 | 0.383 | Anticonvulsant | 0.206 0.079 DBMET00314 | ||
| 0.367 | 0.008 | 0.367 | 5 Hydroxytryptamine 2A antagonist | 0.235 0.016 DBMET00314 | ||
| 0.379 | 0.026 | 0.379 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.335 0.043 DBMET00314 | ||
| 0.39 | 0.038 | 0.602 | Vasodilator, coronary | 0.391 0.038 DBMET00314 0.602 0.008 DBMET00679 | DBMET00679 | |
| 0.358 | 0.009 | 0.358 | 5 Hydroxytryptamine 1E antagonist | 0.356 0.009 DBMET00314 | ||
| 0.349 | 0.008 | 0.349 | Antihistaminic | 0.163 0.028 DBMET00314 | ||
| 0.345 | 0.008 | 0.345 | Histamine antagonist | 0.148 0.03 DBMET00314 | ||
| 0.341 | 0.006 | 0.341 | Alpha 1b adrenoreceptor antagonist | 0.285 0.008 DBMET00314 | ||
| 0.339 | 0.006 | 0.339 | Nav1.1 sodium channel blocker | 0.298 0.008 DBMET00314 0.088 0.083 DBMET00679 | ||
| 0.339 | 0.006 | 0.339 | Alpha 2 adrenoreceptor antagonist | 0.31 0.008 DBMET00314 | ||
| 0.338 | 0.005 | 0.338 | Histamine H1 receptor antagonist | 0.199 0.014 DBMET00314 | ||
| 0.333 | 0.005 | 0.333 | Nav1.6 sodium channel blocker | 0.254 0.009 DBMET00314 | ||
| 0.329 | 0.009 | 0.329 | Alpha 1 adrenoreceptor antagonist | 0.276 0.013 DBMET00314 | ||
| 0.324 | 0.01 | 0.324 | Anesthetic local | 0.265 0.017 DBMET00314 | ||
| 0.315 | 0.003 | 0.315 | Sphingomyelinase inhibitor | 0.262 0.004 DBMET00314 0.248 0.004 DBMET00679 | ||
| 0.316 | 0.008 | 0.316 | Alpha 1a adrenoreceptor antagonist | 0.253 0.012 DBMET00314 | ||
| 0.317 | 0.012 | 0.317 | Antiadrenergic | 0.239 0.018 DBMET00314 | ||
| 0.321 | 0.021 | 0.321 | Gastrin inhibitor | 0.263 0.064 DBMET00314 0.226 0.111 DBMET00679 | ||
| 0.312 | 0.012 | 0.312 | Acetylcholine M1 receptor antagonist | 0.298 0.015 DBMET00314 | ||
| 0.311 | 0.011 | 0.311 | Toll-Like receptor 9 antagonist | 0.269 0.017 DBMET00314 | ||
| 0.3 | 0.005 | 0.3 | Alpha 1d adrenoreceptor antagonist | 0.231 0.008 DBMET00314 | ||
| 0.316 | 0.022 | 0.316 | MAP-kinase-activated kinase 5 inhibitor | 0.3 0.03 DBMET00314 | ||
| 0.306 | 0.013 | 0.306 | Adrenaline antagonist | 0.231 0.019 DBMET00314 | ||
| 0.291 | 0.004 | 0.291 | 5 Hydroxytryptamine 1D antagonist | 0.177 0.008 DBMET00314 | ||
| 0.379 | 0.094 | 0.379 | Analgesic | 0.32 0.127 DBMET00314 | ||
| 0.32 | 0.035 | 0.498 | Cyclic AMP phosphodiesterase inhibitor | 0.344 0.027 DBMET00314 0.498 0.007 DBMET00679 | DBMET00679 | |
| 0.29 | 0.005 | 0.316 | Protein kinase C gamma inhibitor | 0.316 0.004 DBMET00314 0.148 0.033 DBMET00679 | DBMET00314 | |
| 0.285 | 0.004 | 0.285 | Histamine H2 receptor antagonist | 0.179 0.006 DBMET00314 | ||
| 0.299 | 0.019 | 0.299 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.214 0.042 DBMET00314 | ||
| 0.283 | 0.004 | 0.283 | Adrenaline uptake inhibitor | 0.188 0.007 DBMET00314 0.069 0.035 DBMET00679 | ||
| 0.285 | 0.006 | 0.285 | 5 Hydroxytryptamine 7 antagonist | 0.174 0.015 DBMET00314 | ||
| 0.287 | 0.011 | 0.287 | Butyrylcholinesterase inhibitor | 0.236 0.017 DBMET00314 | ||
| 0.286 | 0.011 | 0.286 | 5 Hydroxytryptamine 1 antagonist | 0.187 0.018 DBMET00314 | ||
| 0.294 | 0.019 | 0.294 | Cholinergic | 0.243 0.03 DBMET00314 | ||
| 0.279 | 0.005 | 0.279 | 5 Hydroxytryptamine 1B antagonist | 0.167 0.011 DBMET00314 | ||
| 0.348 | 0.075 | 0.349 | Vasodilator, peripheral | 0.349 0.074 DBMET00314 0.326 0.084 DBMET00679 | DBMET00314 | |
| 0.279 | 0.008 | 0.279 | 5 Hydroxytryptamine 3E antagonist | 0.227 0.03 DBMET00314 | ||
| 0.321 | 0.05 | 0.382 | DNA damaging | 0.352 0.04 DBMET00314 0.382 0.032 DBMET00679 | DBMET00679 | |
| 0.303 | 0.032 | 0.35 | Tyrosine 3 hydroxylase inhibitor | 0.35 0.016 DBMET00314 | DBMET00314 | |
| 0.311 | 0.052 | 0.311 | Cardiotonic | 0.248 0.084 DBMET00314 0.177 0.143 DBMET00679 | ||
| 0.267 | 0.007 | 0.267 | 5 Hydroxytryptamine 1F antagonist | 0.138 0.019 DBMET00314 | ||
| 0.311 | 0.052 | 0.318 | Insulysin inhibitor | 0.318 0.048 DBMET00314 | DBMET00314 | |
| 0.258 | 0.004 | 0.258 | Histamine N-methyltransferase inhibitor | 0.236 0.004 DBMET00314 | ||
| 0.295 | 0.047 | 0.295 | Ca(v)3.3 blocker | 0.217 0.158 DBMET00314 | ||
| 0.264 | 0.018 | 0.264 | Acetylcholinesterase inhibitor | 0.244 0.022 DBMET00314 | ||
| 0.278 | 0.034 | 0.397 | Peptidyltransferase inhibitor | 0.28 0.033 DBMET00314 0.397 0.007 DBMET00679 | DBMET00679 | |
| 0.254 | 0.011 | 0.254 | GABA C receptor rho-2 antagonist | 0.249 0.012 DBMET00314 | ||
| 0.238 | 0.005 | 0.267 | Adenylate cyclase stimulant | 0.267 0.004 DBMET00314 0.194 0.016 DBMET00679 | DBMET00314 | |
| 0.327 | 0.098 | 0.327 | Calpain 2 inhibitor | 0.237 0.159 DBMET00314 | ||
| 0.234 | 0.006 | 0.234 | Alpha adrenoreceptor agonist | 0.214 0.007 DBMET00314 | ||
| 0.23 | 0.006 | 0.23 | Nitric-oxide synthase inhibitor | 0.163 0.018 DBMET00314 | ||
| 0.236 | 0.017 | 0.236 | Acetylcholine muscarinic antagonist | 0.217 0.02 DBMET00314 | ||
| 0.223 | 0.005 | 0.223 | Toll-Like receptor 3 antagonist | 0.177 0.009 DBMET00314 | ||
| 0.226 | 0.009 | 0.226 | CXC chemokine 4 receptor antagonist | 0.157 0.014 DBMET00314 | ||
| 0.228 | 0.012 | 0.228 | 5 Hydroxytryptamine agonist | 0.09 0.037 DBMET00314 | ||
| 0.238 | 0.023 | 0.238 | Cholinergic antagonist | 0.212 0.029 DBMET00314 | ||
| 0.267 | 0.052 | 0.267 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.191 0.08 DBMET00314 | ||
| 0.276 | 0.061 | 0.394 | Interleukin agonist | 0.255 0.075 DBMET00314 0.394 0.02 DBMET00679 | DBMET00679 | |
| 0.226 | 0.012 | 0.232 | Neuropeptide Y1 antagonist | 0.232 0.011 DBMET00314 | DBMET00314 | |
| 0.219 | 0.009 | 0.219 | MAP3K9 inhibitor | 0.207 0.013 DBMET00314 0.127 0.101 DBMET00679 | ||
| 0.322 | 0.113 | 0.514 | Histamine release inhibitor | 0.417 0.067 DBMET00314 0.514 0.024 DBMET00679 | DBMET00679 | |
| 0.26 | 0.054 | 0.26 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.222 0.111 DBMET00314 | ||
| 0.216 | 0.013 | 0.216 | 5 Hydroxytryptamine 1A antagonist | 0.153 0.02 DBMET00314 | ||
| 0.227 | 0.024 | 0.227 | Acetylcholine antagonist | 0.202 0.03 DBMET00314 | ||
| 0.209 | 0.009 | 0.209 | Dopamine agonist | 0.207 0.009 DBMET00314 0.068 0.046 DBMET00679 | ||
| 0.216 | 0.017 | 0.216 | Dopamine antagonist | 0.216 0.017 DBMET00314 | ||
| 0.197 | 0.005 | 0.197 | Glutamate (mGluR7) agonist | 0.13 0.022 DBMET00314 | ||
| 0.26 | 0.068 | 0.327 | Superoxide dismutase inhibitor | 0.327 0.042 DBMET00314 | DBMET00314 | |
| 0.201 | 0.01 | 0.355 | Dopamine D1 antagonist | 0.355 0.005 DBMET00314 | DBMET00314 | |
| 0.196 | 0.009 | 0.196 | GABA C receptor rho-1 antagonist | 0.172 0.014 DBMET00314 | ||
| 0.254 | 0.069 | 0.456 | Antiamyloidogenic | 0.358 0.037 DBMET00314 0.456 0.02 DBMET00679 | DBMET00679 | |
| 0.212 | 0.028 | 0.351 | ATPase inhibitor | 0.212 0.028 DBMET00314 0.351 0.004 DBMET00679 | DBMET00679 | |
| 0.2 | 0.018 | 0.2 | Falcipain 3 inhibitor | 0.17 0.028 DBMET00314 | ||
| 0.188 | 0.007 | 0.188 | Acetylcholine M4 receptor antagonist | 0.105 0.024 DBMET00314 | ||
| 0.243 | 0.063 | 0.243 | Neuropeptide Y2 antagonist | 0.233 0.074 DBMET00314 | ||
| 0.193 | 0.016 | 0.6 | Mediator release inhibitor | 0.235 0.011 DBMET00314 0.6 0.004 DBMET00679 | DBMET00679 | |
| 0.201 | 0.025 | 0.213 | DNA intercalator | 0.193 0.028 DBMET00314 0.213 0.022 DBMET00679 | DBMET00679 | |
| 0.188 | 0.013 | 0.277 | Protein kinase C zeta inhibitor | 0.277 0.006 DBMET00314 | DBMET00314 | |
| 0.188 | 0.014 | 0.188 | Protein kinase C mu inhibitor | 0.158 0.023 DBMET00314 | ||
| 0.185 | 0.012 | 0.224 | Prolactin inhibitor | 0.224 0.005 DBMET00314 | DBMET00314 | |
| 0.185 | 0.012 | 0.185 | Dopamine D3 antagonist | 0.15 0.015 DBMET00314 | ||
| 0.212 | 0.041 | 0.212 | Antipruritic | 0.206 0.045 DBMET00314 | ||
| 0.229 | 0.059 | 0.229 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.192 0.083 DBMET00314 | ||
| 0.176 | 0.007 | 0.176 | Acetylcholine release stimulant | 0.14 0.024 DBMET00314 0.149 0.017 DBMET00679 | ||
| 0.184 | 0.017 | 0.204 | Interleukin 8 antagonist | 0.204 0.012 DBMET00314 | DBMET00314 | |
| 0.172 | 0.005 | 0.172 | Protein kinase C eta inhibitor | 0.16 0.007 DBMET00314 0.108 0.015 DBMET00679 | ||
| 0.273 | 0.108 | 0.711 | Antithrombotic | 0.287 0.097 DBMET00314 0.711 0.008 DBMET00679 | DBMET00679 | |
| 0.196 | 0.032 | 0.196 | Calcium channel blocker | 0.121 0.087 DBMET00314 | ||
| 0.189 | 0.028 | 0.231 | Adenylate cyclase inhibitor | 0.231 0.021 DBMET00314 0.149 0.046 DBMET00679 | DBMET00314 | |
| 0.177 | 0.019 | 0.177 | Dopamine D2 antagonist | 0.177 0.019 DBMET00314 | ||
| 0.192 | 0.033 | 0.192 | Toll-Like receptor antagonist | 0.185 0.036 DBMET00314 | ||
| 0.179 | 0.022 | 0.179 | 5 Hydroxytryptamine 3A agonist | 0.166 0.027 DBMET00314 | ||
| 0.219 | 0.065 | 0.23 | Anesthetic general | 0.23 0.059 DBMET00314 0.212 0.068 DBMET00679 | DBMET00314 | |
| 0.158 | 0.004 | 0.158 | Protein kinase C beta inhibitor | 0.156 0.004 DBMET00314 0.084 0.025 DBMET00679 | ||
| 0.173 | 0.02 | 0.173 | GABA C receptor antagonist | 0.155 0.027 DBMET00314 | ||
| 0.163 | 0.01 | 0.163 | Acetylcholine M2 receptor antagonist | 0.133 0.014 DBMET00314 | ||
| 0.168 | 0.015 | 0.168 | Dopamine D4 antagonist | 0.128 0.02 DBMET00314 | ||
| 0.184 | 0.033 | 0.281 | MAO A inhibitor | 0.281 0.017 DBMET00314 | DBMET00314 | |
| 0.211 | 0.067 | 0.276 | Neurotrophic factor enhancer | 0.27 0.028 DBMET00314 0.276 0.026 DBMET00679 | DBMET00679 | |
| 0.153 | 0.009 | 0.153 | Dopamine D4 agonist | 0.077 0.02 DBMET00314 | ||
| 0.153 | 0.009 | 0.153 | Alpha 1 adrenoreceptor agonist | 0.122 0.012 DBMET00314 | ||
| 0.159 | 0.02 | 0.159 | Neuropeptide Y antagonist | 0.106 0.037 DBMET00314 | ||
| 0.158 | 0.019 | 0.158 | Telomerase inhibitor | 0.116 0.027 DBMET00314 | ||
| 0.142 | 0.007 | 0.142 | Alpha 2 adrenoreceptor agonist | 0.121 0.01 DBMET00314 | ||
| 0.142 | 0.009 | 0.142 | Acetylcholine M5 receptor antagonist | 0.114 0.014 DBMET00314 | ||
| 0.144 | 0.011 | 0.144 | Calcium channel L-type blocker | 0.096 0.027 DBMET00314 | ||
| 0.157 | 0.027 | 0.227 | Photosensitizer | 0.154 0.029 DBMET00314 0.227 0.008 DBMET00679 | DBMET00679 | |
| 0.205 | 0.075 | 0.346 | Amyloid beta aggregation inhibitor | 0.346 0.035 DBMET00314 0.222 0.067 DBMET00679 | DBMET00314 | |
| 0.137 | 0.008 | 0.193 | NMDA 2A receptor antagonist | 0.193 0.005 DBMET00314 | DBMET00314 | |
| 0.151 | 0.025 | 0.151 | Acetylcholine agonist | |||
| 0.13 | 0.005 | 0.13 | 5 Hydroxytryptamine 1B agonist | 0.093 0.008 DBMET00314 | ||
| 0.229 | 0.104 | 0.229 | 5 Hydroxytryptamine uptake stimulant | 0.225 0.11 DBMET00314 | ||
| 0.139 | 0.015 | 0.139 | 5 Hydroxytryptamine 1 agonist | 0.049 0.038 DBMET00314 | ||
| 0.155 | 0.031 | 0.155 | Calcium channel (voltage-sensitive) blocker | |||
| 0.215 | 0.093 | 0.353 | Vasodilator | 0.237 0.077 DBMET00314 0.353 0.032 DBMET00679 | DBMET00679 | |
| 0.124 | 0.004 | 0.124 | 5 Hydroxytryptamine 4 antagonist | 0.091 0.009 DBMET00314 | ||
| 0.133 | 0.014 | 0.133 | CXC chemokine receptor antagonist | 0.092 0.029 DBMET00314 | ||
| 0.132 | 0.013 | 0.132 | Protein kinase C alpha inhibitor | 0.1 0.022 DBMET00314 | ||
| 0.124 | 0.006 | 0.124 | 5 Hydroxytryptamine 2 agonist | 0.085 0.013 DBMET00314 | ||
| 0.126 | 0.008 | 0.134 | Dopamine D2 agonist | 0.134 0.007 DBMET00314 0.066 0.019 DBMET00679 | DBMET00314 | |
| 0.124 | 0.006 | 0.124 | Histamine agonist | 0.056 0.031 DBMET00314 | ||
| 0.233 | 0.116 | 0.358 | Hypoxia-inducible factor 1 alpha inhibitor | 0.323 0.055 DBMET00314 0.358 0.042 DBMET00679 | DBMET00679 | |
| 0.12 | 0.004 | 0.12 | 5 Hydroxytryptamine 3B antagonist | 0.054 0.013 DBMET00314 | ||
| 0.158 | 0.043 | 0.349 | Alkylator | 0.178 0.034 DBMET00314 0.349 0.01 DBMET00679 | DBMET00679 | |
| 0.124 | 0.009 | 0.168 | Beta 3 adrenoreceptor antagonist | 0.168 0.005 DBMET00314 | DBMET00314 | |
| 0.129 | 0.014 | 0.146 | Interferon agonist | 0.106 0.024 DBMET00314 0.146 0.011 DBMET00679 | DBMET00679 | |
| 0.135 | 0.021 | 0.135 | Acetylcholine nicotinic agonist | 0.085 0.05 DBMET00314 | ||
| 0.118 | 0.005 | 0.118 | 5 Hydroxytryptamine 7 agonist | 0.114 0.005 DBMET00314 | ||
| 0.166 | 0.053 | 0.24 | MAO inhibitor | 0.24 0.03 DBMET00314 | DBMET00314 | |
| 0.124 | 0.014 | 0.124 | Dopamine uptake inhibitor | 0.086 0.023 DBMET00314 | ||
| 0.144 | 0.037 | 0.263 | DNA repair enzyme inhibitor | 0.138 0.044 DBMET00314 0.263 0.005 DBMET00679 | DBMET00679 | |
| 0.117 | 0.011 | 0.117 | 5 Hydroxytryptamine 6 antagonist | 0.066 0.032 DBMET00314 | ||
| 0.114 | 0.008 | 0.114 | Phospholipase D inhibitor | 0.084 0.029 DBMET00314 | ||
| 0.118 | 0.014 | 0.135 | Acetylcholine M3 receptor antagonist | 0.135 0.013 DBMET00314 | DBMET00314 | |
| 0.106 | 0.004 | 0.106 | Adenylate cyclase 1 inhibitor | 0.096 0.005 DBMET00314 | ||
| 0.168 | 0.066 | 0.195 | Neurotensin receptor agonist | 0.195 0.038 DBMET00314 | DBMET00314 | |
| 0.136 | 0.037 | 0.143 | Transcription factor STAT6 inhibitor | 0.143 0.029 DBMET00314 | DBMET00314 | |
| 0.122 | 0.024 | 0.183 | Adrenaline agonist | 0.183 0.009 DBMET00314 | DBMET00314 | |
| 0.147 | 0.049 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.141 0.071 DBMET00314 0.136 0.089 DBMET00679 | ||
| 0.155 | 0.057 | 0.155 | Histone deacetylase SIRT1 inhibitor | 0.149 0.062 DBMET00314 | ||
| 0.119 | 0.023 | 0.119 | Hematopoietic | 0.105 0.031 DBMET00314 | ||
| 0.178 | 0.082 | 0.192 | P-glycoprotein inhibitor | 0.189 0.071 DBMET00314 0.192 0.07 DBMET00679 | DBMET00679 | |
| 0.124 | 0.029 | 0.124 | Acetylcholine nicotinic antagonist | 0.092 0.044 DBMET00314 | ||
| 0.095 | 0.003 | 0.095 | Histamine H1 receptor agonist | 0.058 0.01 DBMET00314 | ||
| 0.108 | 0.015 | 0.108 | Sigma receptor antagonist | 0.075 0.022 DBMET00314 | ||
| 0.18 | 0.088 | 0.18 | Focal adhesion kinase 2 inhibitor | |||
| 0.114 | 0.023 | 0.127 | Myeloperoxidase inhibitor | 0.127 0.017 DBMET00314 | DBMET00314 | |
| 0.212 | 0.122 | 0.226 | Transcription factor STAT inhibitor | 0.226 0.106 DBMET00314 | DBMET00314 | |
| 0.156 | 0.066 | 0.156 | Protein kinase C nu inhibitor | 0.123 0.089 DBMET00314 | ||
| 0.102 | 0.012 | 0.102 | Protein kinase C epsilon inhibitor | 0.075 0.021 DBMET00314 | ||
| 0.095 | 0.007 | 0.095 | Potassium channel small-conductance Ca-activated blocker | 0.048 0.026 DBMET00314 | ||
| 0.105 | 0.016 | 0.105 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.099 | 0.013 | 0.101 | Interferon inducer | 0.078 0.026 DBMET00314 0.101 0.012 DBMET00679 | DBMET00679 | |
| 0.177 | 0.092 | 0.177 | I kappa B kinase epsilon inhibitor | 0.148 0.122 DBMET00314 | ||
| 0.089 | 0.005 | 0.089 | Sigma 2 receptor antagonist | 0.086 0.005 DBMET00314 | ||
| 0.111 | 0.029 | 0.111 | Glutamate release inhibitor | 0.098 0.046 DBMET00314 0.105 0.036 DBMET00679 | ||
| 0.116 | 0.035 | 0.116 | Protein kinase A inhibitor | 0.095 0.049 DBMET00314 | ||
| 0.1 | 0.02 | 0.1 | Cannabinoid CB1 receptor agonist | |||
| 0.082 | 0.005 | 0.082 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.023 DBMET00314 | ||
| 0.178 | 0.104 | 0.178 | HERG channel blocker | |||
| 0.091 | 0.019 | 0.091 | 5 Hydroxytryptamine 2A agonist | 0.089 0.02 DBMET00314 | ||
| 0.083 | 0.01 | 0.083 | Thromboxane synthase inhibitor | 0.074 0.015 DBMET00314 | ||
| 0.105 | 0.033 | 0.105 | Inducible nitric-oxide synthase inhibitor | 0.078 0.066 DBMET00314 | ||
| 0.132 | 0.06 | 0.186 | Aldehyde dehydrogenase inhibitor | 0.186 0.031 DBMET00314 0.155 0.044 DBMET00679 | DBMET00314 | |
| 0.137 | 0.065 | 0.211 | NADPH oxidase inhibitor | 0.211 0.031 DBMET00314 0.143 0.059 DBMET00679 | DBMET00314 | |
| 0.149 | 0.078 | 0.294 | Diuretic | 0.131 0.093 DBMET00314 0.294 0.023 DBMET00679 | DBMET00679 | |
| 0.122 | 0.052 | 0.122 | Nav1.5 sodium channel blocker | |||
| 0.079 | 0.009 | 0.079 | Histamine H4 receptor antagonist | 0.045 0.041 DBMET00314 | ||
| 0.167 | 0.097 | 0.417 | Non-steroidal antiinflammatory agent | 0.19 0.08 DBMET00314 0.417 0.012 DBMET00679 | DBMET00679 | |
| 0.084 | 0.015 | 0.084 | Potassium channel (Ca-activated) blocker | 0.058 0.047 DBMET00314 | ||
| 0.1 | 0.032 | 0.129 | Glycine receptor antagonist | 0.079 0.058 DBMET00314 0.129 0.014 DBMET00679 | DBMET00679 | |
| 0.1 | 0.032 | 0.171 | NMDA 2 receptor antagonist | 0.171 0.013 DBMET00314 | DBMET00314 | |
| 0.14 | 0.073 | 0.14 | Pregnane X receptor agonist | 0.133 0.093 DBMET00314 | ||
| 0.114 | 0.048 | 0.114 | Gastric antisecretory | |||
| 0.19 | 0.123 | 0.19 | Calpain inhibitor | |||
| 0.109 | 0.043 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.062 DBMET00314 | ||
| 0.075 | 0.009 | 0.075 | Histamine H2 receptor agonist | |||
| 0.178 | 0.113 | 0.178 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.07 | 0.005 | 0.095 | Dopamine autoreceptor agonist | 0.095 0.004 DBMET00314 | DBMET00314 | |
| 0.082 | 0.017 | 0.099 | Beta 1 adrenoreceptor antagonist | 0.099 0.01 DBMET00314 | DBMET00314 | |
| 0.08 | 0.017 | 0.08 | Dopamine transporter inhibitor | 0.051 0.031 DBMET00314 | ||
| 0.076 | 0.012 | 0.076 | Chemokine receptor agonist | |||
| 0.081 | 0.018 | 0.081 | Histone deacetylase SIRT3 inhibitor | 0.069 0.03 DBMET00314 | ||
| 0.096 | 0.033 | 0.096 | Caspase 7 inhibitor | 0.076 0.071 DBMET00314 | ||
| 0.111 | 0.048 | 0.194 | Creatine kinase inhibitor | 0.194 0.011 DBMET00314 | DBMET00314 | |
| 0.082 | 0.019 | 0.082 | 5 Hydroxytryptamine 1A agonist | |||
| 0.105 | 0.044 | 0.171 | NMDA receptor antagonist | 0.171 0.019 DBMET00314 | DBMET00314 | |
| 0.121 | 0.062 | 0.121 | Calcium channel N-type blocker | |||
| 0.074 | 0.016 | 0.074 | Prolactin release inhibitor | 0.073 0.018 DBMET00314 | ||
| 0.072 | 0.014 | 0.081 | Dopamine D5 antagonist | 0.081 0.012 DBMET00314 | DBMET00314 | |
| 0.09 | 0.033 | 0.09 | Viral attachment inhibitor | |||
| 0.066 | 0.009 | 0.066 | Alpha 1d adrenoreceptor agonist | 0.044 0.021 DBMET00314 | ||
| 0.109 | 0.052 | 0.109 | Factor V inhibitor | 0.098 0.075 DBMET00314 | ||
| 0.087 | 0.031 | 0.087 | Toll-Like receptor 7 antagonist | |||
| 0.112 | 0.056 | 0.112 | GABA C receptor agonist | |||
| 0.095 | 0.04 | 0.134 | Opioid kappa receptor antagonist | 0.134 0.02 DBMET00314 | DBMET00314 | |
| 0.072 | 0.017 | 0.072 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.061 | 0.007 | 0.061 | 5 Hydroxytryptamine 1D agonist | |||
| 0.063 | 0.009 | 0.063 | GABA uptake inhibitor | 0.048 0.017 DBMET00314 | ||
| 0.085 | 0.033 | 0.085 | Cannabinoid receptor agonist | |||
| 0.08 | 0.027 | 0.109 | Beta adrenoreceptor antagonist | 0.109 0.013 DBMET00314 | DBMET00314 | |
| 0.102 | 0.05 | 0.102 | Protein kinase C delta inhibitor | 0.092 0.061 DBMET00314 | ||
| 0.145 | 0.092 | 0.145 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.121 0.115 DBMET00314 | ||
| 0.075 | 0.024 | 0.075 | Acetylcholine muscarinic agonist | |||
| 0.103 | 0.053 | 0.103 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.059 DBMET00314 | ||
| 0.068 | 0.018 | 0.09 | Beta 2 adrenoreceptor antagonist | 0.09 0.009 DBMET00314 | DBMET00314 | |
| 0.089 | 0.039 | 0.102 | CC chemokine 5 receptor agonist | 0.102 0.019 DBMET00314 | DBMET00314 | |
| 0.119 | 0.07 | 0.119 | Histone deacetylase class III inhibitor | 0.111 0.078 DBMET00314 | ||
| 0.082 | 0.034 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.105 | 0.058 | 0.105 | Chemokine receptor antagonist | |||
| 0.055 | 0.009 | 0.055 | Delayed rectifier potassium channel blocker | 0.05 0.011 DBMET00314 | ||
| 0.08 | 0.034 | 0.08 | Acetylcholine M5 receptor agonist | |||
| 0.081 | 0.036 | 0.081 | Neuronal nicotinic receptor antagonist | 0.059 0.055 DBMET00314 | ||
| 0.082 | 0.037 | 0.082 | Vanilloid 4 agonist | |||
| 0.136 | 0.092 | 0.148 | Heat shock protein 70 antagonist | 0.144 0.061 DBMET00314 0.148 0.049 DBMET00679 | DBMET00679 | |
| 0.087 | 0.043 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.054 | 0.014 | 0.054 | Histone deacetylase 9 inhibitor | 0.039 0.027 DBMET00314 | ||
| 0.056 | 0.016 | 0.056 | Dopamine D3 agonist | 0.052 0.018 DBMET00314 | ||
| 0.049 | 0.01 | 0.049 | Sigma 1 receptor antagonist | 0.03 0.017 DBMET00314 | ||
| 0.068 | 0.029 | 0.068 | Nicotinic neuronal receptor agonist | |||
| 0.075 | 0.036 | 0.075 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.147 | 0.109 | 0.168 | Lipocortins synthesis antagonist | 0.168 0.083 DBMET00314 0.162 0.089 DBMET00679 | DBMET00314 | |
| 0.06 | 0.022 | 0.06 | Histamine H3 receptor antagonist | |||
| 0.055 | 0.017 | 0.055 | Glutamate (mGluR1a) antagonist | |||
| 0.137 | 0.099 | 0.154 | Growth hormone agonist | 0.154 0.084 DBMET00314 | DBMET00314 | |
| 0.188 | 0.151 | 0.195 | Transcription factor STAT3 inhibitor | 0.195 0.141 DBMET00314 | DBMET00314 | |
| 0.063 | 0.026 | 0.063 | Myc inhibitor | 0.049 0.047 DBMET00314 | ||
| 0.05 | 0.014 | 0.05 | Nociceptin (N/OFQ) receptor antagonist | 0.036 0.024 DBMET00314 | ||
| 0.066 | 0.031 | 0.066 | Calcium channel T-type blocker | |||
| 0.042 | 0.007 | 0.042 | Protein kinase C beta I inhibitor | 0.041 0.008 DBMET00314 0.037 0.014 DBMET00679 | ||
| 0.055 | 0.021 | 0.055 | CC chemokine 4 receptor antagonist | |||
| 0.131 | 0.097 | 0.131 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.043 | 0.01 | 0.043 | CXC chemokine receptor agonist | |||
| 0.067 | 0.034 | 0.067 | Calcium channel P-type blocker | |||
| 0.035 | 0.003 | 0.035 | CXC chemokine 4 receptor agonist | 0.023 0.005 DBMET00314 | ||
| 0.035 | 0.005 | 0.035 | Glutaminyl-peptide cyclotransferase inhibitor | 0.021 0.016 DBMET00314 | ||
| 0.087 | 0.057 | 0.087 | Calcium antagonist | |||
| 0.055 | 0.026 | 0.06 | Squalene epoxidase inhibitor | 0.06 0.021 DBMET00314 | DBMET00314 | |
| 0.051 | 0.021 | 0.051 | Histone deacetylase 8 inhibitor | 0.04 0.03 DBMET00314 | ||
| 0.064 | 0.036 | 0.064 | Carbonic anhydrase stimulant | |||
| 0.04 | 0.011 | 0.04 | Protein kinase C beta II inhibitor | 0.039 0.012 DBMET00314 | ||
| 0.084 | 0.056 | 0.108 | Estrogen-related receptor beta agonist | 0.108 0.017 DBMET00314 | DBMET00314 | |
| 0.052 | 0.024 | 0.052 | Cytokine production stimulant | 0.05 0.029 DBMET00679 | ||
| 0.04 | 0.012 | 0.04 | Adenosine uptake inhibitor | |||
| 0.052 | 0.025 | 0.052 | Acetylcholine M1 receptor agonist | |||
| 0.063 | 0.036 | 0.074 | Beta 2 adrenoreceptor agonist | 0.074 0.013 DBMET00314 | DBMET00314 | |
| 0.087 | 0.06 | 0.087 | Bromodomain-containing protein 2 inhibitor | |||
| 0.123 | 0.097 | 0.123 | Cytidine deaminase inhibitor | |||
| 0.049 | 0.023 | 0.049 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.195 | 0.169 | 0.514 | Cholesterol antagonist | 0.249 0.126 DBMET00314 0.514 0.03 DBMET00679 | DBMET00679 | |
| 0.118 | 0.092 | 0.129 | Vanilloid 1 agonist | 0.129 0.068 DBMET00314 0.118 0.093 DBMET00679 | DBMET00314 | |
| 0.038 | 0.012 | 0.038 | Thrombin receptor antagonist | |||
| 0.039 | 0.014 | 0.039 | Melatonin receptor 1A agonist | 0.031 0.029 DBMET00314 | ||
| 0.101 | 0.076 | 0.101 | GABA receptor agonist | |||
| 0.045 | 0.02 | 0.045 | Histone deacetylase 7 inhibitor | |||
| 0.046 | 0.021 | 0.088 | Dopamine D5 agonist | 0.088 0.005 DBMET00314 | DBMET00314 | |
| 0.05 | 0.026 | 0.05 | Benzodiazepine antagonist | |||
| 0.033 | 0.01 | 0.033 | Myristoyl transferase inhibitor | |||
| 0.048 | 0.025 | 0.048 | Geranyltranstransferase inhibitor | |||
| 0.027 | 0.004 | 0.027 | Melatonin receptor 1A antagonist | 0.013 0.01 DBMET00314 | ||
| 0.195 | 0.174 | 0.63 | Transcription factor NF kappa B inhibitor | 0.297 0.096 DBMET00314 0.63 0.028 DBMET00679 | DBMET00679 | |
| 0.105 | 0.083 | 0.109 | Beta amyloid protein antagonist | 0.109 0.078 DBMET00679 | DBMET00679 | |
| 0.075 | 0.053 | 0.075 | CYP2A6 inhibitor | |||
| 0.165 | 0.144 | 0.192 | ErbB-1 antagonist | 0.192 0.099 DBMET00314 | DBMET00314 | |
| 0.038 | 0.017 | 0.038 | Melatonin agonist | 0.033 0.022 DBMET00314 | ||
| 0.039 | 0.019 | 0.048 | RNA-directed RNA polymerase inhibitor | 0.048 0.014 DBMET00314 | DBMET00314 | |
| 0.039 | 0.019 | 0.039 | Growth hormone releasing factor agonist | |||
| 0.056 | 0.036 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.052 0.05 DBMET00314 | ||
| 0.027 | 0.008 | 0.027 | Histamine H4 receptor agonist | |||
| 0.062 | 0.043 | 0.076 | NMDA 2C receptor antagonist | 0.076 0.028 DBMET00314 | DBMET00314 | |
| 0.055 | 0.037 | 0.055 | Epithelial sodium channel blocker | |||
| 0.087 | 0.068 | 0.087 | Polo-like kinase-1 inhibitor | |||
| 0.028 | 0.01 | 0.028 | 5 Hydroxytryptamine 4 agonist | |||
| 0.055 | 0.037 | 0.055 | Nicotinic alpha7 receptor agonist | |||
| 0.083 | 0.065 | 0.126 | Opioid antagonist | 0.126 0.034 DBMET00314 | DBMET00314 | |
| 0.054 | 0.038 | 0.054 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.025 | 0.01 | 0.025 | Apolipoprotein B inhibitor | |||
| 0.034 | 0.019 | 0.034 | Vanilloid 4 antagonist | |||
| 0.141 | 0.126 | 0.312 | DNA methylase inhibitor | 0.194 0.083 DBMET00314 0.312 0.025 DBMET00679 | DBMET00679 | |
| 0.053 | 0.039 | 0.053 | Cannabinoid CB2 receptor agonist | |||
| 0.065 | 0.052 | 0.065 | Glutamate (mGluR7) antagonist | |||
| 0.05 | 0.036 | 0.05 | Alpha 1b adrenoreceptor agonist | |||
| 0.038 | 0.025 | 0.041 | Kinesin-like protein 1 inhibitor | 0.041 0.021 DBMET00314 | DBMET00314 | |
| 0.038 | 0.025 | 0.041 | Kinesin antagonist | 0.041 0.021 DBMET00314 | DBMET00314 | |
| 0.029 | 0.017 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 DBMET00314 | DBMET00314 | |
| 0.029 | 0.018 | 0.029 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.024 | 0.012 | 0.024 | Growth hormone release promoting | |||
| 0.039 | 0.028 | 0.039 | 5 Hydroxytryptamine 2B agonist | |||
| 0.033 | 0.022 | 0.035 | Melatonin 2 agonist | 0.035 0.021 DBMET00314 | DBMET00314 | |
| 0.106 | 0.096 | 0.106 | Cathepsin H inhibitor | |||
| 0.116 | 0.106 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.047 | 0.037 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.049 0.033 DBMET00314 | DBMET00314 | |
| 0.048 | 0.039 | 0.048 | Sodium/calcium exchanger inhibitor | |||
| 0.029 | 0.02 | 0.029 | Cyclin E2 inhibitor | |||
| 0.028 | 0.019 | 0.028 | Melatonin antagonist | |||
| 0.026 | 0.017 | 0.026 | Acid ceramidase inhibitor | |||
| 0.041 | 0.033 | 0.079 | NMDA receptor subunit 3B antagonist | 0.079 0.014 DBMET00314 | DBMET00314 | |
| 0.032 | 0.025 | 0.032 | Melatonin 1 agonist | |||
| 0.058 | 0.051 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.017 | 0.009 | 0.021 | NMDA receptor phencyclidine site antagonist | 0.021 0.006 DBMET00314 | DBMET00314 | |
| 0.156 | 0.149 | 0.473 | Immunostimulant | 0.178 0.134 DBMET00314 0.473 0.033 DBMET00679 | DBMET00679 | |
| 0.041 | 0.034 | 0.041 | Nerve growth factor antagonist | |||
| 0.059 | 0.053 | 0.059 | Fibroblast growth factor 2 antagonist | |||
| 0.073 | 0.068 | 0.096 | MAP kinase kinase 7 inhibitor | 0.096 0.017 DBMET00314 | DBMET00314 | |
| 0.018 | 0.013 | 0.018 | Alpha 2c adrenoreceptor agonist | |||
| 0.012 | 0.008 | 0.012 | Melatonin 2 antagonist | |||
| 0.054 | 0.049 | 0.054 | Bombesin 1 receptor agonist | |||
| 0.055 | 0.051 | 0.055 | Cyclin D1 inhibitor | |||
| 0.033 | 0.029 | 0.033 | Ceramide glucosyltransferase inhibitor | |||
| 0.235 | 0.231 | 0.541 | Apoptosis agonist | 0.354 0.137 DBMET00314 0.541 0.063 DBMET00679 | DBMET00679 | |
| 0.171 | 0.167 | 0.312 | DNA synthesis inhibitor | 0.173 0.163 DBMET00314 0.312 0.04 DBMET00679 | DBMET00679 | |
| 0.034 | 0.031 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.034 | 0.031 | 0.034 | Antidiuretic hormone antagonist | |||
| 0.131 | 0.128 | 0.29 | DNA methyltransferase I inhibitor | 0.179 0.08 DBMET00314 0.29 0.03 DBMET00679 | DBMET00679 | |
| 0.017 | 0.015 | 0.017 | Melatonin 1 antagonist | |||
| 0.075 | 0.073 | 0.075 | GABA A receptor agonist | |||
| 0.029 | 0.027 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.052 | 0.05 | 0.052 | Protein kinase C iota inhibitor | |||
| 0.087 | 0.086 | 0.087 | Ferrochelatase inhibitor | |||
| 0.089 | 0.088 | 0.089 | Adenylate kinase inhibitor | |||
| 0.058 | 0.057 | 0.058 | Histone deacetylase inhibitor | |||
| 0.1 | 0.102 | 0.104 | Sphingosine 1-phosphate receptor 2 agonist | 0.104 0.091 DBMET00314 | DBMET00314 | |
| 0.044 | 0.046 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.024 DBMET00314 | DBMET00314 | |
| 0.085 | 0.087 | 0.106 | Anabolic | 0.106 0.055 DBMET00314 | DBMET00314 | |
| 0.109 | 0.113 | 0.28 | Peroxidase inhibitor | 0.28 0.041 DBMET00314 | DBMET00314 | |
| 0.083 | 0.087 | 0.242 | Topoisomerase I inhibitor | 0.151 0.041 DBMET00314 0.242 0.018 DBMET00679 | DBMET00679 | |
| 0.074 | 0.08 | 0.124 | MAO B inhibitor | 0.124 0.049 DBMET00314 | DBMET00314 | |
| 0.114 | 0.121 | 0.257 | Insulin secretagoues | 0.124 0.105 DBMET00314 0.257 0.018 DBMET00679 | DBMET00679 | |
| 0.042 | 0.049 | 0.05 | Beta adrenoreceptor agonist | 0.05 0.017 DBMET00314 | DBMET00314 | |
| 0.021 | 0.031 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 DBMET00679 | DBMET00679 | |
| 0.092 | 0.104 | 0.111 | TRPA1 agonist | 0.111 0.071 DBMET00314 | DBMET00314 | |
| 0.015 | 0.027 | 0.02 | Estrogen-related receptor gamma agonist | 0.02 0.01 DBMET00314 | DBMET00314 | |
| 0.023 | 0.036 | 0.033 | HCV NS5B polymerase inhibitor | 0.033 0.02 DBMET00314 | DBMET00314 | |
| 0.027 | 0.04 | 0.052 | NMDA receptor subunit 3A antagonist | 0.052 0.019 DBMET00314 | DBMET00314 | |
| 0.103 | 0.116 | 0.27 | Protein kinase stimulant | 0.14 0.075 DBMET00314 0.27 0.022 DBMET00679 | DBMET00679 | |
| 0.053 | 0.069 | 0.075 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.041 DBMET00314 | DBMET00314 | |
| 0.043 | 0.06 | 0.08 | Alpha-mannosidase inhibitor | 0.08 0.011 DBMET00679 | DBMET00679 | |
| 0.145 | 0.164 | 0.178 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.178 0.096 DBMET00314 | DBMET00314 | |
| 0.093 | 0.112 | 0.119 | Alpha-N-acetylglucosaminidase inhibitor | 0.119 0.079 DBMET00679 | DBMET00679 | |
| 0.074 | 0.093 | 0.107 | Alcohol dehydrogenase inhibitor | 0.107 0.046 DBMET00314 0.083 0.075 DBMET00679 | DBMET00314 | |
| 0.06 | 0.08 | 0.086 | Analgesic, opioid | 0.086 0.041 DBMET00314 | DBMET00314 | |
| 0.131 | 0.153 | 0.141 | Succinate dehydrogenase inhibitor | 0.141 0.13 DBMET00314 | DBMET00314 | |
| 0.082 | 0.106 | 0.255 | Topoisomerase II inhibitor | 0.157 0.046 DBMET00314 0.255 0.024 DBMET00679 | DBMET00679 | |
| 0.105 | 0.131 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.06 DBMET00314 | DBMET00314 | |
| 0.129 | 0.156 | 0.15 | Phospholipase C inhibitor | 0.15 0.106 DBMET00314 | DBMET00314 | |
| 0.019 | 0.046 | 0.051 | Arginase inhibitor | 0.051 0.014 DBMET00679 | DBMET00679 | |
| 0.043 | 0.071 | 0.057 | Androgen agonist | 0.057 0.045 DBMET00314 | DBMET00314 | |
| 0.066 | 0.094 | 0.083 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.083 0.059 DBMET00314 | DBMET00314 | |
| 0.091 | 0.121 | 0.149 | Toll-Like receptor 2 antagonist | 0.149 0.053 DBMET00314 | DBMET00314 | |
| 0.226 | 0.264 | 0.313 | 5 Hydroxytryptamine release inhibitor | 0.249 0.23 DBMET00314 0.313 0.151 DBMET00679 | DBMET00679 | |
| 0.091 | 0.129 | 0.286 | Lipid peroxidase inhibitor | 0.19 0.046 DBMET00314 0.286 0.021 DBMET00679 | DBMET00679 | |
| 0.045 | 0.084 | 0.064 | Heat shock protein 90 beta antagonist | 0.064 0.034 DBMET00314 | DBMET00314 | |
| 0.028 | 0.071 | 0.071 | Mannosidase inhibitor | 0.071 0.011 DBMET00679 | DBMET00679 | |
| 0.076 | 0.124 | 0.116 | Phosphodiesterase 6D inhibitor | 0.116 0.029 DBMET00679 | DBMET00679 | |
| 0.074 | 0.121 | 0.124 | Chelator | 0.124 0.05 DBMET00314 | DBMET00314 | |
| 0.059 | 0.109 | 0.097 | Estrogen receptor alpha antagonist | 0.097 0.029 DBMET00314 | DBMET00314 | |
| 0.024 | 0.075 | 0.083 | Phosphorylase inhibitor | 0.083 0.016 DBMET00679 | DBMET00679 | |
| 0.038 | 0.09 | 0.08 | Opioid mu receptor antagonist | 0.08 0.04 DBMET00314 | DBMET00314 | |
| 0.083 | 0.135 | 0.277 | Cyclooxygenase 3 inhibitor | 0.108 0.092 DBMET00314 0.277 0.007 DBMET00679 | DBMET00679 | |
| 0.181 | 0.234 | 0.312 | 15-Lipoxygenase inhibitor | 0.312 0.124 DBMET00314 | DBMET00314 | |
| 0.031 | 0.085 | 0.075 | Opioid delta receptor antagonist | 0.075 0.038 DBMET00314 | DBMET00314 | |
| 0.019 | 0.073 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 DBMET00679 | DBMET00679 | |
| 0.065 | 0.121 | 0.106 | NADH dehydrogenase inhibitor | 0.106 0.038 DBMET00679 | DBMET00679 | |
| 0.114 | 0.175 | 0.148 | MAP kinase kinase 4 inhibitor | 0.148 0.066 DBMET00314 | DBMET00314 | |
| 0.011 | 0.076 | 0.025 | Dopamine D1 agonist | 0.025 0.013 DBMET00679 | DBMET00679 | |
| 0.061 | 0.129 | 0.093 | Triose-phosphate isomerase inhibitor | 0.093 0.056 DBMET00679 | DBMET00679 | |
| 0.062 | 0.132 | 0.12 | ATPase (Vacuolar H+) inhibitor | 0.12 0.02 DBMET00679 | DBMET00679 | |
| 0.04 | 0.111 | 0.085 | Na+ K+ transporting ATPase inhibitor | 0.085 0.045 DBMET00679 | DBMET00679 | |
| 0.092 | 0.163 | 0.12 | Phospholipase A2 inhibitor | 0.12 0.118 DBMET00314 | DBMET00314 | |
| 0.165 | 0.236 | 0.293 | Caspase 3 stimulant | 0.253 0.11 DBMET00314 0.293 0.082 DBMET00679 | DBMET00679 | |
| 0.171 | 0.246 | 0.392 | Interleukin 2 agonist | 0.224 0.151 DBMET00314 0.392 0.03 DBMET00679 | DBMET00679 | |
| 0.072 | 0.151 | 0.101 | Microtubule formation inhibitor | 0.101 0.089 DBMET00679 | DBMET00679 | |
| 0.054 | 0.133 | 0.13 | Cell adhesion molecule inhibitor | 0.13 0.02 DBMET00679 | DBMET00679 | |
| 0.045 | 0.127 | 0.057 | Heme oxygenase stimulant | 0.057 0.055 DBMET00314 | DBMET00314 | |
| 0.162 | 0.246 | 0.4 | Apoptosis antagonist | 0.229 0.148 DBMET00314 0.4 0.038 DBMET00679 | DBMET00679 | |
| 0.087 | 0.171 | 0.235 | Cell wall synthesis inhibitor | 0.235 0.019 DBMET00679 | DBMET00679 | |
| 0.102 | 0.191 | 0.224 | Interferon gamma antagonist | 0.128 0.115 DBMET00314 0.224 0.034 DBMET00679 | DBMET00679 | |
| 0.03 | 0.121 | 0.066 | Phosphofructokinase-1 inhibitor | 0.066 0.051 DBMET00679 | DBMET00679 | |
| 0.021 | 0.115 | 0.067 | Antibiotic Aminoglycoside-like | 0.067 0.007 DBMET00679 | DBMET00679 | |
| 0.01 | 0.104 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.017 DBMET00679 | DBMET00679 | |
| 0.067 | 0.163 | 0.115 | Bone formation stimulant | 0.115 0.09 DBMET00314 0.105 0.101 DBMET00679 | DBMET00314 | |
| 0.051 | 0.15 | 0.093 | Bronchodilator | 0.093 0.072 DBMET00314 | DBMET00314 | |
| 0.061 | 0.16 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.074 DBMET00314 | DBMET00314 | |
| 0.054 | 0.162 | 0.111 | UDP-glucose 4-epimerase inhibitor | 0.111 0.05 DBMET00679 | DBMET00679 | |
| 0.07 | 0.186 | 0.155 | Estrogen antagonist | 0.155 0.022 DBMET00314 | DBMET00314 | |
| 0.102 | 0.218 | 0.285 | Platelet antagonist | 0.285 0.058 DBMET00679 | DBMET00679 | |
| 0.106 | 0.225 | 0.373 | Tumour necrosis factor alpha release inhibitor | 0.373 0.032 DBMET00679 | DBMET00679 | |
| 0.065 | 0.19 | 0.099 | DOPA decarboxylase inhibitor | 0.099 0.077 DBMET00314 | DBMET00314 | |
| 0.147 | 0.274 | 0.288 | Sodium/bile acid cotransporter inhibitor | 0.288 0.09 DBMET00314 0.232 0.148 DBMET00679 | DBMET00314 | |
| 0.057 | 0.195 | 0.103 | Multidrug resistance-associated protein 1 inhibitor | 0.103 0.073 DBMET00679 | DBMET00679 | |
| 0.068 | 0.205 | 0.222 | Cell adhesion inhibitor | 0.222 0.019 DBMET00679 | DBMET00679 | |
| 0.048 | 0.195 | 0.099 | Cystathionine beta-synthase inhibitor | 0.099 0.078 DBMET00314 | DBMET00314 | |
| 0.081 | 0.228 | 0.27 | NOS3 expression enhancer | 0.14 0.084 DBMET00314 0.27 0.023 DBMET00679 | DBMET00679 | |
| 0.009 | 0.161 | 0.068 | Estrogen agonist | 0.068 0.027 DBMET00314 | DBMET00314 | |
| 0.004 | 0.162 | 0.035 | Estrogen receptor alpha agonist | 0.035 0.023 DBMET00314 | DBMET00314 | |
| 0.016 | 0.177 | 0.038 | Estrogen-related receptor beta antagonist | 0.038 0.013 DBMET00314 | DBMET00314 | |
| 0.03 | 0.193 | 0.134 | Topoisomerase II alpha inhibitor | 0.071 0.06 DBMET00314 0.134 0.026 DBMET00679 | DBMET00679 | |
| 0.009 | 0.175 | 0.039 | Protein 30S ribosomal subunit inhibitor | 0.039 0.01 DBMET00679 | DBMET00679 | |
| 0.034 | 0.201 | 0.07 | Macrophage migration inhibitory factor inhibitor | 0.07 0.066 DBMET00314 | DBMET00314 | |
| 0.072 | 0.251 | 0.189 | Hexokinase inhibitor | 0.189 0.042 DBMET00679 | DBMET00679 | |
| 0.008 | 0.194 | 0.035 | Sodium/glucose cotransporter inhibitor | 0.035 0.008 DBMET00679 | DBMET00679 | |
| 0.006 | 0.194 | 0.034 | Sodium/glucose cotransporter 2 inhibitor | 0.034 0.01 DBMET00679 | DBMET00679 | |
| 0.045 | 0.244 | 0.104 | Thioredoxin inhibitor | 0.104 0.044 DBMET00679 | DBMET00679 | |
| 0.044 | 0.246 | 0.179 | AMP-activated protein kinase stimulant | 0.179 0.015 DBMET00679 | DBMET00679 | |
| 0.046 | 0.251 | 0.271 | Thrombolytic | 0.271 0.029 DBMET00679 | DBMET00679 | |
| 0.129 | 0.337 | 0.588 | Antibacterial | 0.588 0.021 DBMET00679 | DBMET00679 | |
| 0.043 | 0.253 | 0.159 | Beta glucuronidase inhibitor | 0.159 0.021 DBMET00679 | DBMET00679 | |
| 0.023 | 0.234 | 0.074 | Heparanase inhibitor | 0.074 0.009 DBMET00679 | DBMET00679 | |
| 0.033 | 0.246 | 0.161 | Expectorant | 0.161 0.031 DBMET00679 | DBMET00679 | |
| 0.074 | 0.288 | 0.166 | Melanin inhibitor | 0.166 0.063 DBMET00679 | DBMET00679 | |
| 0.016 | 0.239 | 0.312 | Selectin antagonist | 0.312 0.005 DBMET00679 | DBMET00679 | |
| 0.101 | 0.331 | 0.238 | Angiogenesis inhibitor | 0.238 0.132 DBMET00679 | DBMET00679 | |
| 0.04 | 0.273 | 0.127 | Estrogen receptor beta antagonist | 0.127 0.025 DBMET00314 | DBMET00314 | |
| 0.101 | 0.334 | 0.442 | Immunosuppressant | 0.442 0.049 DBMET00679 | DBMET00679 | |
| 0.106 | 0.34 | 0.358 | Immunomodulator | 0.358 0.057 DBMET00679 | DBMET00679 | |
| 0.068 | 0.307 | 0.184 | Interleukin 6 antagonist | 0.184 0.052 DBMET00679 | DBMET00679 | |
| 0.087 | 0.326 | 0.175 | Lipoxygenase inhibitor | 0.175 0.169 DBMET00314 | DBMET00314 | |
| 0.049 | 0.303 | 0.19 | Anticoagulant | 0.19 0.057 DBMET00679 | DBMET00679 | |
| 0.087 | 0.348 | 0.394 | Alpha-glucosidase inhibitor | 0.394 0.118 DBMET00679 | DBMET00679 | |
| 0.051 | 0.317 | 0.124 | Interleukin 4 antagonist | 0.119 0.087 DBMET00314 0.124 0.08 DBMET00679 | DBMET00679 | |
| 0.033 | 0.305 | 0.063 | Lipocortins synthesis agonist | 0.063 0.031 DBMET00679 | DBMET00679 | |
| 0.063 | 0.339 | 0.235 | Hemostatic | 0.235 0.024 DBMET00679 | DBMET00679 | |
| 0.037 | 0.318 | 0.235 | Amylase inhibitor | 0.235 0.033 DBMET00679 | DBMET00679 | |
| 0.014 | 0.303 | 0.084 | Protein 50S ribosomal subunit inhibitor | 0.084 0.018 DBMET00679 | DBMET00679 | |
| 0.06 | 0.352 | 0.353 | Hepatoprotectant | 0.353 0.019 DBMET00679 | DBMET00679 | |
| 0.053 | 0.364 | 0.461 | Free radical scavenger | 0.21 0.09 DBMET00314 0.461 0.02 DBMET00679 | DBMET00679 | |
| 0.06 | 0.378 | 0.499 | Antioxidant | 0.208 0.108 DBMET00314 0.499 0.02 DBMET00679 | DBMET00679 | |
| 0.039 | 0.36 | 0.553 | Angiogenesis stimulant | 0.553 0.009 DBMET00679 | DBMET00679 | |
| 0.012 | 0.364 | 0.097 | Monophenol monooxygenase inhibitor | 0.097 0.078 DBMET00679 | DBMET00679 | |
| 0.043 | 0.437 | 0.095 | Interleukin 12 antagonist | 0.095 0.063 DBMET00679 | DBMET00679 | |
| 0.032 | 0.43 | 0.146 | Toll-Like receptor 4 antagonist | 0.146 0.023 DBMET00679 | DBMET00679 | |
| 0.04 | 0.444 | 0.304 | Nitric oxide antagonist | 0.304 0.04 DBMET00679 | DBMET00679 | |
| 0.039 | 0.455 | 0.078 | T cell inhibitor | 0.078 0.075 DBMET00679 | DBMET00679 | |
| 0.005 | 0.469 | 0.119 | Antineoplastic antibiotic | 0.119 0.039 DBMET00679 | DBMET00679 | |
| 0.009 | 0.478 | 0.062 | Neuraminidase (influenza) inhibitor | 0.062 0.048 DBMET00679 | DBMET00679 | |
| 0.033 | 0.518 | 0.11 | Transcription factor NF kappa B stimulant | 0.11 0.031 DBMET00679 | DBMET00679 | |
| 0.027 | 0.519 | 0.095 | DNA polymerase I inhibitor | 0.095 0.092 DBMET00679 | DBMET00679 | |
| 0.021 | 0.524 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.039 DBMET00679 | DBMET00679 | |
| 0.023 | 0.53 | 0.194 | Hypolipemic | 0.194 0.099 DBMET00679 | DBMET00679 | |
| 0.054 | 0.669 | 0.635 | Antiinflammatory | 0.635 0.044 DBMET00679 | DBMET00679 | |
| 0.036 | 0.698 | 0.635 | Cyclophilin D inhibitor | 0.635 0.022 DBMET00679 | DBMET00679 | |
| 0.01 | 0.686 | 0.062 | Glucose-6-phosphate translocase inhibitor | 0.062 0.022 DBMET00679 | DBMET00679 | |
| 0.029 | 0.719 | 0.498 | Hypoglycemic | 0.498 0.015 DBMET00679 | DBMET00679 | |
| 0.062 | 0.778 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.081 DBMET00679 | DBMET00679 | |
| 0.017 | 0.76 | 0.281 | Platelet adhesion inhibitor | 0.281 0.04 DBMET00679 | DBMET00679 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |